After the first therapy and a time when the cancer could not be discovered, recurrence indicates that the disease has returned. Some cancer cells may persist in the body even after a successful course of treatment and lie latent for months or years before beginning to proliferate once more.

Dr Radheshyam Naik, a medical oncologist and hematologist consultant at Bengaluru's Sammprada Multi-speciality Hospital, told a Lifestyle Magazine that recurrence might occur months or even years after treatment, underscoring the need for long-term follow-up. Different forms of breast cancer recurrence:

1. Local recurrence: The cancer reappears either in the same breast or in the scar left by a mastectomy.

2. Regional recurrence: The cancer returns to the lymph nodes close by, such as those around the collarbone or beneath the arm.

3. Metastatic breast cancer: Stage 4 cancer in which the cancer has spread to other areas of the body, such as the liver, lungs, brain, or bones.

The likelihood of relapse, according to Dr. Radheshyam Naik, is contingent upon several variables, including the kind and stage of the original cancer, the status of hormone receptors, the status of HER2, the kind of treatment received (surgery, chemotherapy, radiation, hormone therapy), the body's reaction to the initial treatment, and so on.

The existing methods or technologies for identifying early indicators of breast cancer recurrence and effectiveness.

• Pet scan imaging: PET-CT is an extremely effective technique for identifying metastases, although it is not typically used unless symptoms appear.
• MRI: Useful for identifying tiny lesions in high-risk individuals, dense breast tissue, and surgical scars, which mammography may overlook.
• However, indicators like CA 15-3, CEA, and CA 27.29 are trustworthy enough to be utilized by themselves for early identification. Monitoring hormonal treatment adherence and efficacy in patients with hormone-positive malignancies can help lower the risk of recurrence but cannot directly identify it.
• Some people have circulating tumor cells and circulating tumor DNA in their bloodstream. Although they work well, it is impossible to identify a tiny return.

Does the frequency with which breast cancer survivors should be screened or monitored for recurrence differ depending on the stage or kind of their initial diagnosis?

"Generally once in six months," was Dr. Radheshyam Naik's response. We may monitor early cancers once a year and more advanced malignancies once every six months. To identify any indications of recurrence in its early stages, breast cancer patients should be checked frequently. The first year should have follow-up appointments every six months, followed by annual follow-up appointments.

He pointed out, "The frequency and intensity of monitoring can differ depending on the stage and type of the original cancer — more advanced or aggressive cancers need more frequent follow-ups. Survivors should quickly inform their doctor about any new or unusual symptoms."

Read Also: Don’t Confuse Monsoon Sweat with Moisture: How Face Mists Can Truly Hydrate Your Skin

Get the latest Bollywood entertainment news, trending celebrity news, latest celebrity news, new movie reviews, latest entertainment news, latest Bollywood news, and Bollywood celebrity fashion & style updates!

HOW DID YOU LIKE THIS ARTICLE? CHOOSE YOUR EMOTICON!